Lucchese, Guglielmo
 Distribuzione geografica
Continente #
AS - Asia 1.775
NA - Nord America 1.471
EU - Europa 588
SA - Sud America 284
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 25
OC - Oceania 1
Totale 4.295
Nazione #
US - Stati Uniti d'America 1.261
SG - Singapore 1.010
IT - Italia 465
HK - Hong Kong 317
CN - Cina 281
BR - Brasile 229
CA - Canada 89
VN - Vietnam 84
BD - Bangladesh 37
DE - Germania 31
AR - Argentina 25
GB - Regno Unito 25
PR - Porto Rico 25
CW - ???statistics.table.value.countryCode.CW??? 22
CR - Costa Rica 21
AT - Austria 19
MX - Messico 16
GP - Guadalupe 15
RU - Federazione Russa 12
IN - India 9
SV - El Salvador 9
ZA - Sudafrica 9
EC - Ecuador 8
GT - Guatemala 8
NI - Nicaragua 7
NL - Olanda 7
TT - Trinidad e Tobago 7
ID - Indonesia 6
IQ - Iraq 6
PY - Paraguay 6
CO - Colombia 5
ES - Italia 5
HN - Honduras 5
JM - Giamaica 5
JP - Giappone 5
LT - Lituania 5
FR - Francia 4
MA - Marocco 4
PL - Polonia 4
UZ - Uzbekistan 4
CL - Cile 3
KE - Kenya 3
KW - Kuwait 3
PE - Perù 3
RO - Romania 3
TR - Turchia 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
LY - Libia 2
NP - Nepal 2
PK - Pakistan 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
EG - Egitto 1
GE - Georgia 1
HT - Haiti 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
LB - Libano 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SE - Svezia 1
UA - Ucraina 1
Totale 4.166
Città #
Council Bluffs 347
Hong Kong 315
Singapore 251
Ashburn 167
Milan 129
San Jose 118
Beijing 114
Santa Clara 53
Rome 49
Princeton 37
Ho Chi Minh City 24
Los Angeles 23
Hanoi 22
Willemstad 22
New York 21
Nuremberg 18
São Paulo 18
Miano 17
Montreal 17
San José 17
Turin 16
Naples 15
Bari 13
Dallas 12
San Juan 11
North Bergen 10
Vienna 10
Abbeville 9
Mexico City 9
Atlanta 8
Rio de Janeiro 8
San Salvador 8
Toronto 8
Brescia 7
Brooklyn 7
Johannesburg 7
London 7
Managua 7
Carrboro 6
Chicago 6
Laval 6
Belo Horizonte 5
Berlin 5
Catania 5
Charlotte 5
Denver 5
Frankfurt am Main 5
Guatemala City 5
Orem 5
Phoenix 5
Taranto 5
Tokyo 5
Brasília 4
Buenos Aires 4
Carolina 4
Duque de Caxias 4
Pescara 4
Pointe-à-Pitre 4
Quito 4
Quận Bốn 4
Scarborough 4
Tampa 4
Tashkent 4
Vancouver 4
Warsaw 4
Bologna 3
Calgary 3
Campinas 3
Casablanca 3
Centro Municipality 3
Chennai 3
Contagem 3
Da Nang 3
Florence 3
Genoa 3
Guayaquil 3
Haiphong 3
Hamilton 3
Heredia 3
Itaquaquecetuba 3
Las Vegas 3
Lima 3
Lévis 3
Manaus 3
Niagara Falls 3
Petrópolis 3
Piracicaba 3
Quảng Ninh 3
Reading 3
Recife 3
San Francisco 3
Seattle 3
São Bernardo do Campo 3
São Vicente 3
Tegucigalpa 3
Thái Bình 3
Treviso 3
Verona 3
Allentown 2
Amsterdam 2
Totale 2.179
Nome #
Anti-neuronal antibodies against brainstem antigens are associated with COVID-19 74
An epitope platform for safe and effective HTLV-1-immunization: Potential applications for mRNA and peptide-based vaccines 69
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein 68
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 62
A Systematic Review Focusing on the Link between Engineered Nanoparticles and Neurodegeneration 61
Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein. 59
Circumscribing the conformational peptide epitope landscape 58
Brain oscillatory processes related to sequence memory in healthy older adults 56
Bacterial peptides are intensively present throughout the human proteome 55
Comparison of dry and wet electroencephalography for the assessment of cognitive evoked potentials and sensor-level connectivity 55
Clinical applications of DNA microarray analysis 55
An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines 55
Chapter 33 - Impact of COVID-19 on the brain: Antibodies against brain stem antigens 54
Natalizumab treatment affects cognitive performances, fatigue and health related quality of life in Relapsing Multiple Sclerosis 53
A spiking neurocomputational model of high-frequency oscillatory brain responses to words and pseudowords 53
Changes of Cognitive Performances, Fatigue and Health Related Quality of Life in Natalizumab-Treated Relapsing Multiple Sclerosis Patients 52
Charting the peptide crossreactome between HIV-1 and the human proteome 52
A peptide link between HCMV infection, neuronal migration, and psychosis 52
Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response 52
Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons 51
H1N1 versus H5N1 hemagglutinins: A possible differential immunologic impact on neurodevelopment 51
Cerebrospinal fluid findings in COVID-19 indicate autoimmunity 50
Reconciling forgetting and memory consolidation: simulating the dissociable effects of neuronal noise levels on cortical memory 50
A peptide talk between JC virus and the human host: from silent infection to autoimmunity 49
Massive peptide sharing between viral and human proteomes 47
SARS-CoV-2 and Guillain-Barré Syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism 47
Zusammensetzungen zur Behandlung von COVID-19-assoziierter Autoimmun-Hirnstamm- Enzephalitis 46
Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes 46
Communicative-pragmatic assessment is sensitive and time-effective in measuring the outcome of aphasia therapy 45
Anti-neuronal and anti-mitochondrial autoantibodies are associated with lower functional status and more severe respiratory symptoms in post COVID syndrome 45
Zika virus and autoimmunity: From microcephaly to Guillain-Barre syndrome, and beyond 45
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 45
Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors 44
Impact of COVID‑19 emergency on the psychological well‑being of susceptible individuals 44
Electrophysiological correlates of language improvements after intensive language therapy in patients with chronic post-stroke aphasia 44
COVID19 outbreak in Lombardy, Italy: An analysis on the short-term relationship between air pollution, climatic factors and the susceptibility to SARS-CoV-2 infection 43
Peptide matching between Epstein–Barr virus and human proteins 41
Geographical variations in sex ratio trends over time in Multiple Sclerosis 41
Immune Response Against SARS-CoV-2 41
Verbal Fluency Impairment in Patients with Clinically Isolated Syndrome Suggestive of Multipla Sclerosis 41
Epitopes for a 2019-nCoV vaccine 40
Does communication make aphasia therapy more efficient?: Evidence from a cross-over randomized controlled trial 40
Neuropragmatic Speech-Language Deficits Specific To Speech Act Type Following Left-Hemispheric Lesion 40
Reconciling forgetting and memory consolidation: Simulating the dissociable effects of neuronal noise levels on cortical memory traces in 30th Annual Computational Neuroscience Meeting 40
Early and interactive stored-form (symbol) access and combinatorial (rule) processing in constructing constructions: a MMN study 40
Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors. 40
Geographic Differences in the Temporal Trend of Gender Ratio in Multiple Sclerosis 39
No human protein is exempt from bacterial motifs, not even one 39
Sentence Construction by Stored-Form Retrieval and by Combination: ERP Evidence for Early and Interactive Processing 39
Gender ratio of Multiple Sclerosis in Italy: geographical distribution and trend over 60 years 38
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude 38
Intensive social interaction for treatment of post-stroke depression in subacute aphasia: The CONNECT trial 37
EBV and Molecular Mimicry: Therapeutic Implications 37
EBV-Associated Cancer and Autoimmunity: Searching for Therapies 37
Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins 37
Differential effects of intensive language-action therapy on processing grammatical word class and semantics demonstrated by functional magnetic resonance imaging 37
Increased recruitment of domain general neural networks in language processing following Intensive Language-Action Therapy – fMRI evidence from people with chronic aphasia 36
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection. 36
Natural history of multiple sclerosis: have available therapies impacted long-term prognosis? 36
Neuropragmatic Speech-Language Deficits Specific To Speech Act Type Following Left-Hemispheric Lesion 35
Peptidology: short amino acid modules in cell biology and immunology 35
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome 35
Understanding neuropsychiatric diseases, analyzing the peptide sharing between infectious agents and the Language-associated NMDA 2A protein 35
Proteome-guided search for influenza A B-cell epitopes 35
Epitopes for a 2019-nCoV vaccine 35
Increasing age at disability milestones among MS patients in the MSBase Registry 35
West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses 35
Relationships between Plasma Osteopontin Levels and Cognitive Performances in Relapsing Multiple Sclerosis: Effect of Natalizumab Treatment 35
Therapy-Induced Neuroplasticity of Language in Chronic Post Stroke Aphasia: A Mismatch Negativity Study of (A)Grammatical And Meaningful/less Mini-Constructions 34
Sex ratio of multiple sclerosis: a comparison of distribution and trend over 60 years among different countries 34
Using language for communication and action makes intensive aphasia therapy more effective: a crossover randomized controlled trial 34
Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia 34
Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry 34
PSYCHOLOGICAL GENERAL WELL-BEING, COGNITIVE FAILURE, AND INFLAMMATION BIOMARKERS AMONG WORKERS FOUR MONTHS AFTER A MILD/ASYMPTOMATIC SARS-CoV-2 INFECTION 34
Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B 34
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry 33
The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond 33
Impact of natalizumab treatment on cognitive performance, fatigue and health-related quality of life in relapsing multiple sclerosis 33
Confronting JC virus and Homo sapiens biological signatures 33
Cytomegalovirus infection: The neurodevelopmental peptide signatures 33
Developing an anti-Campylobacter jejuni vaccine 32
Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial 32
The peptide network between tetanus toxin and human proteins associated with epilepsy 32
From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between T. gondii and NMDARs as a Potential Mechanistic Link 32
Electrophysiological Evidence for Early and Interactive Symbol Access and Rule Processing in Retrieving and Combining Language Constructions 32
Peptide profiling of the route from Mahoney to Sabin, and return 32
Occupational zoonoses, neurological diseases, and public health: A one health approach 32
How a single amino acid change may alter the immunological information of a peptide 32
Reply concerning the article "Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond" 31
Herpesviruses, autoimmunity and epilepsy: Peptide sharing and potential cross-reactivity with human synaptic proteins 31
Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis 31
Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining 30
Cross-Reactivity as a Mechanism Linking Infections to Stroke 30
Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide 30
Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis 30
Degenerate binding of tyrosinase peptides to MHC II Ad/Ed molecules 30
Single amino acid repeats connect viruses to neurodegeneration 30
Peptide sharing between viruses and DLX Proteins: a potential cross-reactivity pathway to neuropsychiatric disorders 30
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study 30
Treating multiple sclerosis with natalizumab 29
Totale 4.113
Categoria #
all - tutte 20.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.910


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025718 0 0 0 104 4 230 48 17 18 65 144 88
2025/20261.888 254 351 250 227 67 61 138 56 203 99 131 51
2026/20271.689 107 363 133 885 201 0 0 0 0 0 0 0
Totale 4.295